Hookipa Pharma company info

What does Hookipa Pharma do?
Hookipa Pharma (NASDAQ:HOOK) is a biotechnology company focused on developing a new class of immunotherapeutics based on its proprietary arenavirus platform technologies. The company is dedicated to creating innovative treatments for infectious diseases and cancers, harnessing the power of the immune system to combat these serious conditions. Through its cutting-edge research and development, Hookipa is advancing a diverse pipeline of potential therapies, including novel vaccines and immune-oncology products. The company's objectives revolve around transforming the therapeutic landscape by delivering highly effective, durable, and safe options for patients in need across the globe. With a relentless pursuit of groundbreaking solutions, Hookipa is committed to making a meaningful difference in the lives of those affected by challenging diseases.
Hookipa Pharma company media
Company Snapshot

Is Hookipa Pharma a public or private company?

key
Ownership
Public

How many people does Hookipa Pharma employ?

people
Employees
151

What sector is Hookipa Pharma in?

pie chart
Sector
Health Care

Where is the head office for Hookipa Pharma?

location pin
Head Office
New York, United States

What year was Hookipa Pharma founded?

founded flag
Year Founded
2011
What does Hookipa Pharma specialise in?
/Immunotherapy Development /Cancer Treatments /Infectious Diseases /Viral Vector Technologies /Biotech Innovation /Medical Research

What are the products and/or services of Hookipa Pharma?

Overview of Hookipa Pharma offerings
HB-101, a prophylactic cytomegalovirus vaccine, aiming to prevent congenital CMV infection.
HB-200 series, using an arenavirus platform for HPV16+ cancers, including head, neck, and cervical cancers.
HB-300, a therapeutic vaccine targeting human papillomavirus-positive cancers.
Oncology viral vector platforms, focusing on arenavirus-based vectors for solid tumors.
Immuno-oncology programs, developing novel arenavirus-based therapeutics to reprogram the immune system against cancer.
Research collaborations, partnering with biotech and pharma for vaccine and immuno-oncology development.

Who is in the executive team of Hookipa Pharma?

Hookipa Pharma leadership team
  • Mr. Joern  Aldag
    Mr. Joern Aldag
    CEO & Director
  • Dr. Reinhard  Kandera Ph.D.
    Dr. Reinhard Kandera Ph.D.
    CFO & Director
  • Prof. Rolf M. Zinkernagel M.D., Ph.D.
    Prof. Rolf M. Zinkernagel M.D., Ph.D.
    Co-Founder
  • Mr. Andreas  Bergthaler
    Mr. Andreas Bergthaler
    Co-Founder
  • Mr. Lukas  Flatz
    Mr. Lukas Flatz
    Co-Founder
  • Dr. Roman  Necina Ph.D.
    Dr. Roman Necina Ph.D.
    Chief Operations Officer
  • Dr. Klaus  Orlinger Ph.D.
    Dr. Klaus Orlinger Ph.D.
    Chief Scientific Officer
  • Mr. Matthew L. S. Beck
    Mr. Matthew L. S. Beck
    Executive Director of Investor Relations